Abstract
Over activation of the renin‐angiotensin system (RAS) plays a key role in diabetes. ACE2 has been reported to counteract the pathophysiological effects of RAS over activity. To clarify the role of ACE2 in glucose homeostasis, ACE2 KO and control mice (5 months old, n=5/group) were infused with AngII (osmotic pump: 600 ng/kg/min); insulin levels (ng/ml) and glucose tolerance (AUC: mg/dl*120) were assessed after 14 days infusion. KO mice manifested significantly (P<0.05) higher hyperinsulinemia (6.2 ±0.49 vs. 4.5 ±0.23) and glucose intolerance (55300 ±1387 vs. 43550 ±1735) compared to controls, suggesting their hypersensitivity to diabetes. To assess the therapeutic potential of ACE2, βTC‐ 3 cells (mouse insulinoma) were subjected to glucose stimulated insulin secretion assay (2.8, 16, 25 mM glucose) in which AngII significantly (P<0.05) decreased insulin secretion vs. control group (1.01 ±0.01 vs. 1.84 ±0.12; 1.57 ±0.15 vs. 2.78 ±0.05; 1.7 ±0.08 vs. 2.64 ±0.05 ng/ml, respectively). In cells pretreated with an adenovirus over expressing ACE2, insulin secretion was restored (1.75 ±0.14; 2.81 ±0.22; 3.25 ±0.22 ng/ml, respectively), suggesting ACE2 can prevent the Ang‐II mediated inhibitory effect. In conclusion ACE2 is important in the regulation of glucose homeostasis and could be a potential therapeutic target to ameliorate insulin resistance and glucose intolerance resulting from RAS over activation.LSUHSC research enhancement fund.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.